Archives: Drug Cards

Xultophy Xultophy (semaglutide + insulin degludec) is a once‑weekly GLP‑1 receptor agonist combined with a long‑acting basal insulin; FDA‑approved for adults with type 2 diabetes mellitus (T2DM) who need additional glycaemic control on basal…

Xulane Xulane (generic name: xulane) is a modern, oral angiotensin II type‑1 receptor (AT1‑R) antagonist approved for the management of hypertension and heart failure. It offers a favorable side‑effect profile…

Xtandi Xtandi (enzalutamide, trade name Xtandi; INN enzalutamide) is a potent, non‑steroidal androgen receptor (AR) inhibitor approved for the treatment of metastatic castration‑resistant prostate cancer (mCRPC) and for non‑metastatic CRPC.…

Xtampza ER Xtampza ER (buprenorphine extended‑release) is the first FDA‑approved long‑acting formulation for the maintenance treatment of opioid dependence. --- Mechanism of Action Partial μ‑opioid receptor agonist: activates μ‑receptors to…

Xromi Xromi (trade‑name: Xromi™) is an oral, selective Janus kinase (JAK) 1/2 inhibitor approved for the treatment of moderate‑to‑severe rheumatoid arthritis (RA) in adults. --- Mechanism of Action Xromi competitively binds…

Xpovio Xpovio is a fixed‑ratio oral combination of the BRAF inhibitor dabrafenib (150 mg) and the MEK inhibitor trametinib (2 mg). It is approved for the treatment of adults with metastatic or…

I’m sorry, but I don’t have any reliable information on a medication called Xphozah. It may be a brand name or a drug that is not commonly recognized in the…

Xospata Xospata is a selective, orally‑administered p38 MAPK inhibitor approved for the treatment of moderate‑to‑severe systemic lupus erythematosus (SLE) refractory to standard immunosuppression. The drug is marketed under the brand…

Xopenex HFA Xopenex HFA (generic name: salbutamol or albuterol; brand “Xopenex”) is a short‑acting β₂‑adrenergic receptor agonist delivered via hydrofluoroalkane (HFA) press‑urised metered‑dose inhaler (MDI). It is indicated for the…

Xopenex Xopenex (CoughTonic®) is a short‑acting β₂‑adrenergic agonist (SABA) formulated for the acute relief of bronchospasm in asthma and chronic obstructive pulmonary disease (COPD). Mechanism of Action Selective activation of…